Yee K - Search Results

1

MicroRNA-30c targets cytoskeleton genes involved in breast cancer cell invasion.

Bockhorn J, Yee K, Chang YF, Prat A, Huo D, Nwachukwu C, Dalton R, Huang S, Swanson KE, Perou CM, Olopade OI, Clarke MF, Greene GL, Liu H. Bockhorn J, et al. Among authors: yee k. Breast Cancer Res Treat. 2013 Jan;137(2):373-82. doi: 10.1007/s10549-012-2346-4. Epub 2012 Dec 7. Breast Cancer Res Treat. 2013. PMID: 23224145 Free PMC article.

2

MicroRNA-30c inhibits human breast tumour chemotherapy resistance by regulating TWF1 and IL-11.

Bockhorn J, Dalton R, Nwachukwu C, Huang S, Prat A, Yee K, Chang YF, Huo D, Wen Y, Swanson KE, Qiu T, Lu J, Park SY, Dolan ME, Perou CM, Olopade OI, Clarke MF, Greene GL, Liu H. Bockhorn J, et al. Among authors: yee k. Nat Commun. 2013;4:1393. doi: 10.1038/ncomms2393. Nat Commun. 2013. PMID: 23340433 Free PMC article.

3

Decrease in polylactosaminoglycans associated with lysosomal membrane glycoproteins during differentiation of CaCo-2 human colonic adenocarcinoma cells.

Youakim A, Romero PA, Yee K, Carlsson SR, Fukuda M, Herscovics A. Youakim A, et al. Among authors: yee k. Cancer Res. 1989 Dec 15;49(24 Pt 1):6889-95. Cancer Res. 1989. PMID: 2582431

4

Commentary: Efficacy and safety of the innovative monoclonal antibodies in adults with generalized myasthenia gravis: a Bayesian network analysis.

Zhang I, Jansen JP, Yungher BJ, Kielhorn A, Yee KS. Zhang I, et al. Among authors: yee ks. Front Immunol. 2024 May 17;15:1403802. doi: 10.3389/fimmu.2024.1403802. eCollection 2024. Front Immunol. 2024. PMID: 38827748 Free PMC article. No abstract available.

5

Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort study.

Jensen TO, Murray TA, Grandits GA, Jain MK, Grund B, Shaw-Saliba K, Matthay MA, Abassi M, Ardelt M, Baker JV, Chen P, Dewar RL, Goodman AL, Hatlen TJ, Highbarger HC, Holodniy M, Lallemand P, Laverdure S, Leshnower BG, Looney D, Moschopoulos CD, Mugerwa H, Murray DD, Mylonakis E, Nagy-Agren S, Rehman MT, Rupert A, Stevens R, Turville S, Weintrob A, Wick K, Lundgren J, Ko ER; ACTIV-3/TICO Study Group. Jensen TO, et al. Lancet Microbe. 2024 May 27:S2666-5247(24)00015-6. doi: 10.1016/S2666-5247(24)00015-6. Online ahead of print. Lancet Microbe. 2024. PMID: 38815595 Free article.

6

Pharmacokinetics and Bioequivalence of Fixed-Dose Combination of Simvastatin and Ezetimibe Tablets: A Randomized, Crossover, Open-Label Study in Healthy Volunteers.

Leong CW, Yee KM, Rani TA, Lau KJ, Ahmad S, Amran A, Mohd Hassan FW, Kumar N. Leong CW, et al. Among authors: yee km. Clin Pharmacol Drug Dev. 2024 May 15. doi: 10.1002/cpdd.1411. Online ahead of print. Clin Pharmacol Drug Dev. 2024. PMID: 38745538

7

Dealing With Variable Drug Exposure Due to Variable Hepatic Metabolism: A Proof-of-Concept Application of Liquid Biopsy in Renal Impairment.

Rostami-Hodjegan A, Al-Majdoub ZM, von Grabowiecki Y, Yee KL, Sahoo S, Breitwieser W, Galetin A, Gibson C, Achour B. Rostami-Hodjegan A, et al. Among authors: yee kl. Clin Pharmacol Ther. 2024 May 13. doi: 10.1002/cpt.3291. Online ahead of print. Clin Pharmacol Ther. 2024. PMID: 38738484

8

Apixaban Pharmacokinetics and Bioequivalence of Two Tablet Formulations: A Randomized, Open-Label, Crossover Study, Fasting Condition in Healthy Indonesian Volunteers.

Leong CW, Yee KM, Liew I, Khaleb NA, Ahmad S, Rani TA, Lau KJ, Yunaidi DA, Simanjuntak R, Ginanjar VA. Leong CW, et al. Among authors: yee km. Clin Pharmacol Drug Dev. 2024 Apr 30. doi: 10.1002/cpdd.1409. Online ahead of print. Clin Pharmacol Drug Dev. 2024. PMID: 38685874

9

Biochemical and biological characterization of the venoms of Naja kaouthia and Naja mandalayensis from Myanmar and neutralization effects of BPI cobra antivenom.

Win MN, Yee KT, Htwe KM, Thin EE, Win SM, Kyaw AM, Aye MM, Khaing KK, Thwe WM, Htwe KK, Zaw A. Win MN, et al. Among authors: yee kt. Toxicon X. 2024 Apr 3;22:100196. doi: 10.1016/j.toxcx.2024.100196. eCollection 2024 Jun. Toxicon X. 2024. PMID: 38665175 Free PMC article.

10

Clinical investigator perspectives on patient outcomes in children with neuronopathic mucopolysaccharidosis II during intrathecal idursulfase-IT treatment.

Yee KS, Alexanderian D, Martin S, Olayinka-Amao B, Whiteman DAH. Yee KS, et al. Orphanet J Rare Dis. 2024 Apr 12;19(1):158. doi: 10.1186/s13023-024-03147-4. Orphanet J Rare Dis. 2024. PMID: 38610004 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

776 results

Search Page